Drug Shortage Report for ZITHROMAX FOR INTRAVENOUS INJECTION
Report ID | 108753 |
Drug Identification Number | 02239952 |
Brand name | ZITHROMAX FOR INTRAVENOUS INJECTION |
Common or Proper name | ZITHROMAX FOR INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 X 5mL vials |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-16 |
Estimated end date | |
Actual end date | 2020-10-01 |
Shortage status | Resolved |
Updated date | 2020-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-10-05 | French | Compare |
v11 | 2020-10-05 | English | Compare |
v10 | 2020-09-09 | French | Compare |
v9 | 2020-09-09 | English | Compare |
v8 | 2020-05-04 | French | Compare |
v7 | 2020-05-04 | English | Compare |
v6 | 2020-05-04 | French | Compare |
v5 | 2020-05-04 | English | Compare |
v4 | 2020-03-17 | English | Compare |
v3 | 2020-03-16 | French | Compare |
v2 | 2020-03-16 | English | Compare |
v1 | 2020-03-16 | English | Compare |
Showing 1 to 12 of 12